NATIONAL COMMUNITY PHARMACISTS ASSOCIATION for NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Alcohol and Drug Abuse ALC
Implementation of pharmacy provisions of Public Law 115-271; H.R. 280, the PDMPs Help Patients Act of 2021; H.R. 2355, the Opioid Prescription Verification Act of 2021; H.R. 768, the Block, Report, And Suspend Suspicious Shipments Act of 2021; Draft legislation, Ensuring Parity in E-Prescribing for Controlled Substances Across Payors
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE CASSITY | — |
| PHILLIP ADAM HARBISON | — |
| RONNA HAUSER | — |
| KARRY LA VIOLETTE | — |
| PETER JOHN MIHALICK | — |
Medicare/Medicaid MMM
H.R. 3554 / S. 1909, the Pharmacy DIR Reform To Reduce Senior Drug Costs Act; H.R. 2608, the Ensuring Seniors Access to Local Pharmacies Act; H.R. 2759 / S. 1362, the Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 3682, the Improving Transparency to Lower Drug Costs Act; H.R. 2484, the Lowest Price for Patients Act; H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act; H.R. 19 / S. 2164, the Lower Costs, More Cures Act of 2021; H.R. 3173, the Improving Seniors Timely Access to Care Act of 2021; H.R. 4121, the PRO Seniors Act; Proposed inclusion of Medicaid managed care spread pricing prohibition to pay for H.R. 3684, the Infrastructure Investment and Jobs Act; H.R. 5237, the Reduced Costs and Continued Cures Act of 2021 H.R. 5376, the Build Back Better Act; H.R. 5804, the Expanding Access to Diabetes Self-Management Training Act of 2021; H.R. 6101, the Drug Price Transparency in Medicaid Act of 2021; Part B billing and COVID oral antivirals; S. 3700, the Affordable Insulin Now Act; H.R. 7213, Equitable Community Access to Pharmacist Services Act; CY 2023 Medicare Advantage and Part D Proposed Rule (CMS-4192-P)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE CASSITY | — |
| PHILLIP ADAM HARBISON | — |
| RONNA HAUSER | — |
| KARRY LA VIOLETTE | — |
| PETER JOHN MIHALICK | — |
Pharmacy PHA
S. 298 / H.R. 1829, the Pharmacy Benefit Manager Accountability Study Act of 2021; H.R. 3655, the Vaccine Injury Compensation Modernization Act of 2021; H.R. 3656, the Vaccine Access Improvement Act of 2021; H.R. 3662, the Patient Access to Urgent-Use Pharmacy Compounding Act of 2021; COVID vaccine distribution; Pharmacist scope of practice, including authorities established by the Public Readiness and Emergency Preparedness (PREP) Act; H.R. 4390, the PROTECT 340B Act of 2021; S. 1574 / H.R. 5632, the Long-Term Care Pharmacy Definition Act of 2021; Provider Relief Fund; Implementation of Pubic Law 113-54, the Drug Quality and Security Act; H.R. 6005, the Access to Birth Control Act; H.R. 6000, Cures 2.0 Act; H.R. 6519, Patients Right to Know Their Medication Act of 2022; Draft legislation, Pharmacy Price Transparency Protection Act; Draft legislation, Prescription Information Modernization Act;
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE CASSITY | — |
| PHILLIP ADAM HARBISON | — |
| RONNA HAUSER | — |
| KARRY LA VIOLETTE | — |
| PETER JOHN MIHALICK | — |
Taxation/Internal Revenue Code TAX
S. 617 / H.R. 1712, the Death Tax Repeal Act of 2021; H.R. 1381 / S. 480, the Main Street Tax Certainty Act; Draft tax provisions of FY2022 budget reconciliation legislation, including repeal of stepped up basis, S Corps/pass-throughs tax increase proposal, and 199A pass-through Deduction proposal; Treasury Department proposal to require financial institutions reporting deposits and withdrawals of all business and personal accounts to the IRS
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE CASSITY | — |
| PHILLIP ADAM HARBISON | — |
| RONNA HAUSER | — |
| KARRY LA VIOLETTE | — |
| PETER JOHN MIHALICK | — |
Labor Issues/Antitrust/Workplace LBR
S. 225, the Competition and Antitrust Law Enforcement Reform Act of 2021; S. 1388, the Prescription Pricing for the People Act of 2021; H.R. 603 / S. 53, the Raise the Wage Act of 2021; H.R. 7, the Paycheck Fairness Act; Promoting Competition in the American Economy Executive Order; UnitedHealth Group proposed merger of Change Healthcare; Unfair Competition and Anticompetitive Contract Terms; Occupational exposure to COVID-19 and vaccine mandates; FTC 6(b) Study of Pharmacy Benefit Managers
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE CASSITY | — |
| PHILLIP ADAM HARBISON | — |
| RONNA HAUSER | — |
| KARRY LA VIOLETTE | — |
| PETER JOHN MIHALICK | — |
Small Business SMB
H.R. 1799, the PPP Extension Act of 2021; H.R. 1319, the American Rescue Plan Act of 2021; H.R. 2583, the PPP Equity Act of 2021; Interchange Fees/Debit Routing issues; PPP and EIDL funding
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE CASSITY | — |
| PHILLIP ADAM HARBISON | — |
| RONNA HAUSER | — |
| KARRY LA VIOLETTE | — |
| PETER JOHN MIHALICK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.